logo

Spark Therapeutics (ONCE)



Trade ONCE now with
  Date
  Headline
2/1/2021 7:38:43 AM Spark Therapeutics Doses First Participant In Phase 1/2 Study Of Of SPK-3006 For Late-Onset Pompe Disease
11/7/2018 7:52:43 AM Wedbush Is Lowering Spark Therapeutics (ONCE) FY18 Rev. Estimate To 66.7 M From 96.4 M
11/7/2018 7:52:23 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q4 18 Rev. Estimate To 15.1 M From 12.1 M
11/7/2018 7:52:04 AM Wedbush Is Lowering Spark Therapeutics (ONCE) FY18 Estimate To -1.87 From -1.04
11/7/2018 7:51:48 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q4 18 Estimate To -1.51 From -1.40
11/7/2018 7:51:18 AM Wedbush Ups Spark Therapeutics (ONCE) To Neutral From Underperform With $40 Price Target
5/9/2018 9:43:20 AM Wedbush Is Cutting Spark Therapeutics (ONCE) FY18 Rev. Estimate To 72.6 M From 239.5 M
5/9/2018 9:43:08 AM Wedbush Is Lowering Spark Therapeutics (ONCE) Q4 18 Rev. Estimate To 8.7 M From 16.4 M
5/9/2018 9:42:55 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q3 18 Rev. Estimate To 40.1 M From 48.1 M
5/9/2018 9:42:38 AM Wedbush Is Lowering Spark Therapeutics (ONCE) Q2 18 Rev. Estimate To 8.1 M From 150.4 M
5/9/2018 9:42:13 AM Wedbush Is Lowering Spark Therapeutics (ONCE) FY18 Estimate To -2.55 From -1.76
5/9/2018 9:41:58 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q4 18 Estimate To -1.62 From -1.53
5/9/2018 9:41:35 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q3 18 Estimate To -0.76 From -0.66
5/9/2018 9:41:13 AM Wedbush Is Cutting Spark Therapeutics (ONCE) Q2 18 Estimate To 1.08 From 1.68
5/9/2018 9:40:38 AM Wedbush Reiterates Spark Therapeutics (ONCE) At Underperform With $40 Price Target
2/21/2018 7:56:12 AM Wedbush Is Increasing Spark Therapeutics (ONCE) FY18 Rev. Estimate To 239.5 M From 213.3 M
2/21/2018 7:55:48 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q3 18 Rev. Estimate To 48.1 M From 41.1 M
2/21/2018 7:55:37 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q2 18 Rev. Estimate To 150.4 M From 140.8 M
2/21/2018 7:55:26 AM Wedbush Is Raising Spark Therapeutics (ONCE) Q1 18 Rev. Estimate To 24.6 M From 15.0 M
2/21/2018 7:55:04 AM Wedbush Is Increasing Spark Therapeutics (ONCE) FY19 Estimate To -1.76 From -2.30